There was no substantial differences in activities of ERK1/2, NF-κB and β-catenin between cells grown in SCM containing bFGF and EGF and those grown without growth factors as shown for six different melanoma cell populations (Fig 5a) although some variabilities were found between experiments, especially for DMBC11 cells. The gene discussed is MAPK3; the disease is melanoma.